These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12787757)

  • 1. Negative regulation of TCR signaling and T-cell activation by selective protein degradation.
    Jang IK; Gu H
    Curr Opin Immunol; 2003 Jun; 15(3):315-20. PubMed ID: 12787757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
    Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
    J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCR and CD28 are coupled via ZAP-70 to the activation of the Vav/Rac-1-/PAK-1/p38 MAPK signaling pathway.
    Salojin KV; Zhang J; Delovitch TL
    J Immunol; 1999 Jul; 163(2):844-53. PubMed ID: 10395678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of phosphotyrosine signaling networks triggered by CD3 and CD28 costimulation in Jurkat cells.
    Kim JE; White FM
    J Immunol; 2006 Mar; 176(5):2833-43. PubMed ID: 16493040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The amplification of TCR signaling by dynamic membrane microdomains.
    Viola A
    Trends Immunol; 2001 Jun; 22(6):322-7. PubMed ID: 11377292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of TNF receptor type-2 (p75) as a costimulator for IL-2 induction and T cell survival: a functional link to CD28.
    Kim EY; Teh HS
    J Immunol; 2004 Oct; 173(7):4500-9. PubMed ID: 15383581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-CD28 costimulatory molecules present in T cell rafts induce T cell costimulation by enhancing the association of TCR with rafts.
    Yashiro-Ohtani Y; Zhou XY; Toyo-Oka K; Tai XG; Park CS; Hamaoka T; Abe R; Miyake K; Fujiwara H
    J Immunol; 2000 Feb; 164(3):1251-9. PubMed ID: 10640738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunological synapse balances T cell receptor signaling and degradation.
    Lee KH; Dinner AR; Tu C; Campi G; Raychaudhuri S; Varma R; Sims TN; Burack WR; Wu H; Wang J; Kanagawa O; Markiewicz M; Allen PM; Dustin ML; Chakraborty AK; Shaw AS
    Science; 2003 Nov; 302(5648):1218-22. PubMed ID: 14512504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation.
    Bachmann MF; McKall-Faienza K; Schmits R; Bouchard D; Beach J; Speiser DE; Mak TW; Ohashi PS
    Immunity; 1997 Oct; 7(4):549-57. PubMed ID: 9354475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunology. Switching off TCR signaling.
    Malissen B
    Science; 2003 Nov; 302(5648):1162-3. PubMed ID: 14615524
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced surface TCR replenishment mediated by CD28 leads to greater TCR engagement during primary stimulation.
    Schrum AG; Wells AD; Turka LA
    Int Immunol; 2000 Jun; 12(6):833-42. PubMed ID: 10837411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of human IL-7 receptor alpha expression by IL-7 and TCR signaling.
    Alves NL; van Leeuwen EM; Derks IA; van Lier RA
    J Immunol; 2008 Apr; 180(8):5201-10. PubMed ID: 18390701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospho-LAT-independent activation of the ras-mitogen-activated protein kinase pathway: a differential recruitment model of TCR partial agonist signaling.
    Chau LA; Madrenas J
    J Immunol; 1999 Aug; 163(4):1853-8. PubMed ID: 10438919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular framework for two-step T cell signaling: Lck Src homology 3 mutations discriminate distinctly regulated lipid raft reorganization events.
    Patel VP; Moran M; Low TA; Miceli MC
    J Immunol; 2001 Jan; 166(2):754-64. PubMed ID: 11145647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell spreading distinguishes the mechanism of augmentation of T cell activation by integrin-associated protein/CD47 and CD28.
    Reinhold MI; Green JM; Lindberg FP; Ticchioni M; Brown EJ
    Int Immunol; 1999 May; 11(5):707-18. PubMed ID: 10330276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28 co-receptor signal transduction in T-cell activation.
    Blair PJ; Riley JL; Carroll RG; St Louis DC; Levine BL; Saha B; Lee KP; Perrin PJ; Harlan DM; June CH
    Biochem Soc Trans; 1997 May; 25(2):651-7. PubMed ID: 9191174
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in actin dynamics at the T-cell/APC interface: implications for T-cell anergy?
    Sechi AS; Buer J; Wehland J; Probst-Kepper M
    Immunol Rev; 2002 Nov; 189():98-110. PubMed ID: 12445268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PI-3 kinase/Akt pathway and T cell activation: pleiotropic pathways downstream of PIP3.
    Kane LP; Weiss A
    Immunol Rev; 2003 Apr; 192():7-20. PubMed ID: 12670391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZAP-70 and SLP-76 regulate protein kinase C-theta and NF-kappa B activation in response to engagement of CD3 and CD28.
    Herndon TM; Shan XC; Tsokos GC; Wange RL
    J Immunol; 2001 May; 166(9):5654-64. PubMed ID: 11313406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic regulation of T-cell costimulation through TCR-CD28 microclusters.
    Yokosuka T; Saito T
    Immunol Rev; 2009 May; 229(1):27-40. PubMed ID: 19426213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.